European Organisation for Research and Treatment of Cancer - EORTC: Breast Neoplasms trials

The registry lists 33 Breast Neoplasms studies with European Organisation for Research and Treatment of Cancer - EORTC as lead sponsor. 3 are open to participants now and 0 have results posted.

Phase 1 4Phase 2 13Phase 3 11No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• OligoCare TwiCs (Trials Within Cohorts) Trial Comparing Acute Toxicity in Single-fraction vs Multiple-fraction SBRT for Metastasis-directed Treatment (SPRINT)RecruitingNCT06462963Not applicable
• Improvement of Quality of Life Through Supportive Treatments for Hormone Therapy - Related Symptoms in Patients With Early Breast CancerNot yet recruitingNCT06407401Phase 3
• Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)RecruitingNCT05512364Phase 3
• Chemo-free BRCA-targeted Neoadjuvant StrategyWithdrawnNCT05209529Phase 2
• Dissecting the Pathways of Therapy Resistance in Early Breast CancerTerminatedNCT04995575
• Follow-up in Early and Locally Advanced Breast Cancer PatientsCompletedNCT03859453
• Adjuvant Palbociclib in Elderly Patients With Breast CancerActive, not recruitingNCT03609047Phase 2
• Randomized Boost Versus no Boost Irradiation of Early Breast CancerCompletedNCT02295033Phase 3
• Elderly Metastatic Breast Cancer: Pertuzumab-Herceptin vs Pertuzumab-Herceptin-Metronomic Chemotherapy, Followed by T-DM1CompletedNCT01597414Phase 2
• Efficacy Study of Herceptin to Treat HER2-negative CTC Breast CancerCompletedNCT01548677Phase 2
• Male Breast Cancer: Understanding the Biology for Improved Patient CareActive, not recruitingNCT01101425
• BI 2536 in Treating Patients With Recurrent or Metastatic Solid TumorsCompletedNCT00526149Phase 2
• Phase I/II Study of Neoadjuvant Lapatinib in Breast CancerCompletedNCT00450892Phase 1/2
• Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid TumorsCompletedNCT00433602
• Genetic Testing or Clinical Assessment in Determining the Need for Chemotherapy in Women With Breast Cancer That Involves No More Than 3 Lymph NodesCompletedNCT00433589Phase 3
• Lapatinib and Tamoxifen in Treating Patients With Advanced or Metastatic Breast CancerCompletedNCT00424164Phase 1
• Lonafarnib, Trastuzumab, and Paclitaxel in Treating Patients With HER2/Neu-Overexpressing Stage IIIB, Stage IIIC, or Stage IV Breast CancerCompletedNCT00068757Phase 1
• Anastrozole With or Without Gefitinib in Treating Postmenopausal Women With Metastatic or Locally Recurrent Breast CancerCompletedNCT00066378Phase 2
• Gefitinib in Treating Patients With Metastatic Breast Cancer That Has Progressed After Antiestrogen and Nonsteroidal Aromatase Inhibitor TherapyCompletedNCT00066339Phase 2
• Assessing Women's Attitudes About the Risk of Infertility Related to Adjuvant Therapy for Early Breast CancerCompletedNCT00062400Not applicable
• Capecitabine Compared With Vinorelbine in Treating Women With Metastatic Breast CancerTerminatedNCT00049660Phase 2/3
• Combination Chemotherapy With Trastuzumab in Treating Women With Metastatic Breast CancerCompletedNCT00036868Phase 2
• R101933 Combined With Chemotherapy in Treating Patients With Metastatic Breast Cancer That Has Not Responded to Previous ChemotherapyCompletedNCT00028873Phase 2
• Breast-Conserving Therapy Compared With Mastectomy Followed By Radiation Therapy in Treating Women With Locally Advanced Breast Cancer Previously Treated With ChemotherapyTerminatedNCT00028704Phase 3
• Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Women With Large Operable or Locally Advanced or Inflammatory Breast CancerCompletedNCT00017095Phase 3
• Comparison of Complete Axillary Lymph Node Dissection With Axillary Radiation Therapy in Treating Women With Invasive Breast CancerCompletedNCT00014612Phase 3
• ICI 182780 in Treating Women With Stage I or Stage II Primary Breast CancerTerminatedNCT00010153Phase 3
• Combination Chemotherapy Before Surgery in Treating Women With Breast CancerCompletedNCT00008034Phase 1
• Oxaliplatin in Treating Women With Advanced or Metastatic Breast Cancer That Has Not Responded to Previous ChemotherapyTerminatedNCT00006121Phase 2
• Comparison of Two Regimens of Liposomal Doxorubicin in Treating Women With Metastatic Breast CancerCompletedNCT00005980Phase 2
• Vinorelbine Plus Fluorouracil in Treating Women With Metastatic Breast CancerCompletedNCT00003730Not applicable
• Lymph Node Radiation Therapy in Patients With Stage I, Stage II, or Stage III Breast Cancer That Has Been Surgically RemovedStatus unknownNCT00002851Phase 3
• Exemestane Compared With Tamoxifen in Treating Women With Locally Recurrent or Metastatic Breast CancerCompletedNCT00002777Phase 3